One hundred and sixty patients with MCI who scored at least 6 on the 12-item Neuropsychiatric Inventory ( NPI ) were enrolled in this double-blind , multi-center trial and randomized to receive 240mg EGb 761 daily or placebo for a period of 24weeks .